Physician profile
Gyula Soos
NPI 1366448904
$2,417.06
in general payments reported to CMS, 2019-2025
22 companies · $225 in 2025
The $225 reported for 2025 was more than what 77% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $383 · 2020: $199 · 2021: $543 · 2022: $397 · 2023: $374 · 2024: $297 · 2025: $225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $895.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $895.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $533.21 | 2021-2025 | Azstarys |
| Supernus Pharmaceuticals, INC. | $423.71 | 2021-2025 | Qelbree |
| Ironshore Pharmaceuticals INC. | $315.75 | 2019-2024 | Jornay Pm |
| Pfizer INC. | $193.20 | 2019-2023 | |
| Glaxosmithkline, LLC. | $181.38 | 2019-2023 | Bexsero |
| Takeda Pharmaceuticals U.S.A., INC. | $169.52 | 2020-2022 | |
| Sobi, INC | $119.46 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $99.84 | 2025 | Jornay Pm |
| Welch Allyn | $79.00 | 2019 | |
| Sanofi Pasteur INC. | $53.70 | 2021-2023 | |
| Neos Therapeutics, LP | $51.17 | 2019 | |
| Sanofi-Aventis U.S. LLC | $33.11 | 2024-2025 | |
| Tris Pharma INC | $28.07 | 2019 | |
| Seqirus USA INC | $22.22 | 2025 | Flucelvax |
| Allergan, INC. | $17.32 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironwood Pharmaceuticals, INC | $15.26 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $14.67 | 2025 | Neffy |
| Kowa Pharmaceuticals America, INC. | $14.08 | 2025 | Zoryve |
| Genentech USA, INC. | $14.03 | 2019 | |
| Cranial Technologies, INC | $13.75 | 2020 | |
| Merck Sharp & Dohme LLC | $13.16 | 2020 | |
| Adlon Therapeutics L.P. | $11.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gyula Soos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.